Intermountain Healthcare

Intermountain Healthcare is a nonprofit health system headquartered in Salt Lake City, Utah. It operates 22 hospitals and employs approximately 1,100 primary and secondary care physicians across more than 185 clinics within the Intermountain Medical Group. As the largest healthcare provider in the Intermountain West, the organization serves the healthcare needs of residents in Utah and southeastern Idaho, employing over 33,000 individuals. Intermountain Healthcare offers a comprehensive range of medical services, including specialties in cancer, heart health, women's health, newborn care, orthopedics, sports medicine, and diagnostics, among others. In addition to clinical services, the organization also provides health insurance plans through SelectHealth, reinforcing its commitment to delivering high-quality healthcare to the communities it serves.

Robert Allen

President, CEO and Board Member

Nannette Berensen

COO

Erik Decker

Vice President and Chief Information Security Officer

Bert Zimmerli

Senior VP, CFO

24 past transactions

Foodsmart

Series C in 2024
Foodsmart is a digital nutrition platform focused on enhancing health outcomes through personalized dietary recommendations. The company aims to support individuals dealing with chronic diseases and food insecurity by collaborating with health plans and healthcare providers. Its online telehealth application offers real-time guidance across various settings, including homes, workplaces, grocery stores, and restaurants. This comprehensive approach enables users to make healthier food choices and select recipes that can mitigate chronic health issues, thereby promoting overall well-being. By providing access to affordable and tailored healthy eating options, Foodsmart strives to empower individuals to improve their nutrition and health.

CTRL Therapeutics

Seed Round in 2023
CTRL Therapeutics is a biotechnology company based in Toronto, Canada, focused on the development of cell therapies and innovative diagnostic solutions. The company has created a microfluidic platform that enhances the detection of rare circulating tumor cells. This technology is integral to the development of a cancer liquid biopsy test, which aims to predict how patients will respond to targeted therapies. By enabling the evaluation of protein expression on tumor cells, CTRL Therapeutics seeks to provide valuable insights for doctors in tailoring treatment plans for cancer patients.

Tepeyac Community Health Center

Grant in 2022
Tepeyac Community Health Center is a non-profit community health center in Denver that has been providing care to the medically underserved.

Teton Simulation

Acquisition in 2022
Teton Simulation is a software company that specializes in the automatic validation and optimization of 3D printing parameters. The company's technology aims to streamline the traditional print-break-repeat prototyping cycle, thereby accelerating product development and lowering production costs. By leveraging its advanced software, users can enhance their applications through structural behavior analysis and progressive failure analysis, ultimately improving efficiency in the 3D printing process.

Transcarent

Series C in 2022
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.

SCL Health

Acquisition in 2021
SCL Health is a faith-based, nonprofit healthcare organization dedicated to improving the health of the people and communities we serve, especially those who are poor and vulnerable. Founded by the Sisters of Charity of Leavenworth in 1864, our $2.5 billion health network provides comprehensive, coordinated care through 11 hospitals, more than 100 physician clinics, and home health, hospice, mental health and safety-net services primarily in Colorado and Montana. We relentlessly focus on delivering safe, high-quality, effective care to every patient, every time, everywhere. In 2016, SCL Health invested $257 million in community benefit —10 cents of every dollar we earn—to support health improvement in our communities.

Vori Health

Series A in 2021
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.

Classic Air Medical

Acquisition in 2021
Classic Air Medical specializes in air medical transport services across Arizona, Utah, Colorado, Idaho, New Mexico, and Wyoming. The company is known for its commitment to excellent patient care and safety, offering critical care air transport from rural hospitals and emergency scenes. Utilizing both rotor and fixed-wing aircraft, Classic Air Medical ensures rapid and safe transportation for patients in need. In addition to its transport services, the company also focuses on community health education, further enhancing its role in providing comprehensive medical care.

Recursion Pharmaceuticals

Series C in 2019
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.

Healthcare Partners Nevada

Acquisition in 2019
HealthCare Partners Nevada, LLC is a medical group based in Las Vegas, Nevada, with additional locations in Henderson, Mesquite, Pahrump, and Boulder City. Founded in 1996, the company operates a network of medical clinics and specialty care affiliates, offering a wide range of healthcare services. These services include primary care, specialty care, urgent care, and various specialized fields such as cardiology, endocrinology, pediatric care, oncology, and hematology. The organization also provides hospitalist services, house calls, and women’s health services. HealthCare Partners Nevada, LLC emphasizes a patient-centered approach to care and is committed to addressing the long-term health and wellness needs of its patients. Since April 2012, it has operated as a subsidiary of Intermountain Healthcare, Inc.

Velano Vascular

Corporate Round in 2019
Velano Vascular, Inc. is a medical device company based in San Francisco, California, established in 2011. The company specializes in the development of needle-free vascular access devices, particularly its FDA-approved PIVO device. This innovative, single-use, and sterile device allows for blood collection from indwelling peripheral IV lines, significantly reducing the need for traditional needle sticks and central line access. Velano Vascular aims to enhance patient care by providing a painless and efficient blood draw option, thereby improving the experience for hospital inpatients while also offering a safer practice for healthcare providers. Additionally, the PIVO device presents a financially responsible alternative for health systems, addressing the challenges associated with conventional vascular access methods.

Redox

Series C in 2019
Redox, Inc. is a healthtech startup incubator and venture capital firm founded in 2014, based in Madison, Wisconsin. The company specializes in early-stage investments in healthcare information technology, including lab information systems and FDA-approved medical devices. Redox accelerates the development and distribution of healthcare software solutions through its full-service integration platform, designed to facilitate secure and efficient data exchange between healthcare delivery organizations and technology vendors. By creating a comprehensive interoperable network, Redox enables these entities to connect and authorize data sharing, ultimately enhancing patient experiences. The firm focuses on removing technical barriers in healthcare systems, standardizing data, and maintaining integrations, allowing vendors and providers to prioritize the delivery of reliable healthcare services.

Redox

Debt Financing in 2018
Redox, Inc. is a healthtech startup incubator and venture capital firm founded in 2014, based in Madison, Wisconsin. The company specializes in early-stage investments in healthcare information technology, including lab information systems and FDA-approved medical devices. Redox accelerates the development and distribution of healthcare software solutions through its full-service integration platform, designed to facilitate secure and efficient data exchange between healthcare delivery organizations and technology vendors. By creating a comprehensive interoperable network, Redox enables these entities to connect and authorize data sharing, ultimately enhancing patient experiences. The firm focuses on removing technical barriers in healthcare systems, standardizing data, and maintaining integrations, allowing vendors and providers to prioritize the delivery of reliable healthcare services.

Zebra Medical Vision

Series C in 2018
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.

R1 RCM

Post in 2018
R1 RCM is a revenue cycle management partner based in Chicago, Illinois, established in 2003. The company offers technology-driven solutions designed to enhance the financial performance and patient experience for hospitals, healthcare systems, and physician groups. Through its comprehensive services, R1 RCM provides an end-to-end revenue cycle infrastructure, which includes personnel, technology solutions, and process workflows. The R1 Performance Stack, its proven operating model, integrates seamlessly into existing healthcare organizations, improving operational margins and cash flows while focusing on patient, physician, and staff satisfaction. The majority of the company's revenue is derived from operating fees, reflecting its commitment to delivering sustainable improvements in the revenue cycle for its clients.

Tissue Analytics

Series A in 2018
Tissue Analytics, Inc. is a company that develops a mobile application designed to facilitate the measurement and analysis of chronic wounds, burns, and skin conditions. This innovative solution allows home health agencies, nursing homes, and medical practices to send patient photographs and perform wound analysis. The application automatically generates formatted patient reports and enables tracking of patient progress regarding their treatments. Additionally, it provides tools for remote patient evaluation and management, utilizing skin and wound analysis algorithms to measure, segment, and classify images. The platform ensures secure transport of protected health information from the patient's bedside to the provider's desktop. Established in 2014 and based in Baltimore, Maryland, Tissue Analytics operates as a subsidiary of Net Health Systems, Inc. The company has formed a strategic alliance with MolecuLight Inc. to further enhance its offerings.

Empiric Health

Seed Round in 2017
Empiric Health, Inc. is a technology-enabled service platform based in Salt Lake City, Utah, dedicated to enhancing clinical outcomes and operational efficiency for healthcare systems. Founded in 2017 and operating as a subsidiary of Oxeon Partners LLC, the company utilizes proprietary comparative analytics and workflow optimization tools to identify and reduce unwarranted clinical variation. This data-driven approach enables healthcare providers to implement evidence-based care decisions, ultimately lowering costs and improving patient outcomes. By focusing on high-value episodic care, Empiric Health supports clinicians in understanding and optimizing their practice patterns for better performance in healthcare delivery.

Redox

Series B in 2017
Redox, Inc. is a healthtech startup incubator and venture capital firm founded in 2014, based in Madison, Wisconsin. The company specializes in early-stage investments in healthcare information technology, including lab information systems and FDA-approved medical devices. Redox accelerates the development and distribution of healthcare software solutions through its full-service integration platform, designed to facilitate secure and efficient data exchange between healthcare delivery organizations and technology vendors. By creating a comprehensive interoperable network, Redox enables these entities to connect and authorize data sharing, ultimately enhancing patient experiences. The firm focuses on removing technical barriers in healthcare systems, standardizing data, and maintaining integrations, allowing vendors and providers to prioritize the delivery of reliable healthcare services.

Redox

Series B in 2017
Redox, Inc. is a healthtech startup incubator and venture capital firm founded in 2014, based in Madison, Wisconsin. The company specializes in early-stage investments in healthcare information technology, including lab information systems and FDA-approved medical devices. Redox accelerates the development and distribution of healthcare software solutions through its full-service integration platform, designed to facilitate secure and efficient data exchange between healthcare delivery organizations and technology vendors. By creating a comprehensive interoperable network, Redox enables these entities to connect and authorize data sharing, ultimately enhancing patient experiences. The firm focuses on removing technical barriers in healthcare systems, standardizing data, and maintaining integrations, allowing vendors and providers to prioritize the delivery of reliable healthcare services.

Zebra Medical Vision

Series B in 2016
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.

Tute Genomics

Series A in 2015
Tute Genomics is a cloud-based clinical genome interpretation platform based in Provo, Utah, founded in 2012. The company specializes in providing advanced analytical methods for genome analysis, utilizing proprietary machine-learning algorithms to facilitate the analysis and interpretation of entire human genomes. By enabling researchers and clinicians to leverage human genome data, Tute Genomics supports scientific discovery and the development of personalized treatment options. Its platform is designed to help physicians identify genes and biomarkers, ultimately advancing personalized medicine in the life sciences sector.

Tute Genomics

Series A in 2014
Tute Genomics is a cloud-based clinical genome interpretation platform based in Provo, Utah, founded in 2012. The company specializes in providing advanced analytical methods for genome analysis, utilizing proprietary machine-learning algorithms to facilitate the analysis and interpretation of entire human genomes. By enabling researchers and clinicians to leverage human genome data, Tute Genomics supports scientific discovery and the development of personalized treatment options. Its platform is designed to help physicians identify genes and biomarkers, ultimately advancing personalized medicine in the life sciences sector.

VisitPay

Venture Round in 2014
VisitPay LLC is a company that specializes in online patient revenue management solutions, designed to help patients manage their healthcare accounts independently. The platform provides a comprehensive financial engagement tool that consolidates billing information from various healthcare providers and health plans, allowing patients to easily view, verify, and pay their medical bills. By integrating with multiple billing systems, VisitPay enhances the collection of outstanding balances owed by patients, thereby improving revenue for hospitals and health systems. The company also offers a suite of self-pay solutions, including business intelligence, reporting tools, and consulting services aimed at optimizing self-pay management practices. Founded in 2010 and headquartered in Boise, Idaho, VisitPay has an additional office in Lehi, Utah.

Ingram Medical

Series B in 2013
Ingram Medical offers a full range of diabetes testing supplies. Now you can get the quality testing supplies you need, at prices you can afford, delivered right to your home. Serving diabetics for over 15 years. When you submit your information to Ingram Medical by clicking on the FREE METER* icon on our Facebook home page, a Diabetic Benefits Specialist will contact you directly. After collecting some basic information, they will find a medical supplier that best fits your personal needs. You’ll soon be saving time and money on your diabetic testing supplies by receiving reduced costs on your out-of-pocket expenses and having your supplies shipped right to your door.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.